Key Takeaways:
- Changguang Chenxin plans to offer 65.3 million shares at HK$39.88 each.
- The imaging sensor specialist expects to debut on the Hong Kong exchange on April 17.
- The IPO values the company at a significant premium to local peers.
Key Takeaways:

(P1) Chinese imaging sensor designer Changguang Chenxin Microelectronics Co. Ltd. (长光辰芯) is set to raise approximately HK$2.6 billion ($332 million) in its Hong Kong initial public offering, pricing at the top of its expected range.
(P2) "The firm will offer roughly 65.3 million shares at a price of HK$39.88 per share," according to the company's prospectus filed with the Hong Kong Stock Exchange.
(P3) The deal gives the Changchun-based company a market capitalization of over HK$10.4 billion. The offering was multiple times oversubscribed by both institutional and retail investors, triggering a clawback mechanism that increased the allocation to the public tranche.
(P4) Shares are expected to begin trading on the Main Board of the Hong Kong Stock Exchange on April 17. The pricing represents a bet on China's push for technological self-sufficiency in the high-end semiconductor and microelectronics sector.
Changguang Chenxin is a leading designer of CMOS image sensors, which are critical components in industrial, medical, and scientific imaging systems. The company plans to use the majority of the IPO proceeds for research and development into new sensor technologies and to expand its production capacity.
The IPO was led by joint sponsors CICC and CITIC Securities. While the company has not yet disclosed cornerstone investors, the high subscription rate suggests strong institutional demand for domestic semiconductor players, despite recent market volatility.
The listing provides a key test of investor appetite for Chinese technology assets amid ongoing geopolitical tensions. First-day trading on April 17 will be a critical barometer for the valuation of other domestic chip-related companies looking to tap public markets.
This article is for informational purposes only and does not constitute investment advice.